Navigation Links
ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)
Date:7/1/2008

SAN DIEGO, July 1 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: ANX) today announced preliminary response rate results from its discontinued Phase 3 clinical trial of ANX-510, or CoFactor, the Company's folate-based biomodulator of 5-FU (5 fluorouracil), for the treatment of first-line metastatic colorectal cancer. The primary endpoint of the study was progression-free survival, which is expected to mature and be reported by the Company along with safety data later this year.

Data from the 85 patients treated in the study demonstrated a 39.0% objective response rate in the CoFactor/5-FU/Avastin(R) experimental arm compared to a 31.8% objective response rate in the leucovorin/5-FU/Avastin control arm. The data also demonstrated a 48.8% stable disease rate and 4.8% progressive disease rate in the CoFactor experimental arm compared to a 38.6% stable disease rate and 15.9% progressive disease rate in the leucovorin control arm. Objective response rate was measured according to RECIST criteria and was based on the number of complete responses and partial responses observed in this study based on investigators' assessments. In the study, both CoFactor and 5-FU were administered as an i.v. bolus. Currently, there are 10 patients receiving treatment in this study, with 6 patients on the CoFactor experimental arm and 4 patients on the leucovorin control arm.

Based on the data available at this time, the Company intends to evaluate potential options for the continued development of CoFactor. As the Company makes progress it anticipates providing updates regarding its development plans for CoFactor.

"As we evaluate further safety and efficacy data from our Phase 3 trial and the results of our pharmacokinetic bri
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
2. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
3. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
4. ADVENTRX Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of CoFactor(R) for the Treatment of Advanced Breast Cancer
5. ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference
6. ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
7. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
8. ADVENTRX Presents CoFactor Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
9. ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... June 2, 2015 The American Society of ... Practice Guideline for the Use of Medications in the ... ).  The Practice Guideline will assist clinicians ... use. It addresses knowledge gaps about the benefits of ... evidence-based coverage standards by payers. The ...
(Date:6/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/w3n5p6/drug_delivery_in ) ... report "Drug Delivery in Central Nervous System ... their offering. The delivery of drugs ... in the treatment of neurological disorders. Drugs may ... systematically (e.g., by intravenous injection) for targeted action ...
(Date:6/2/2015)... and Markets ( http://www.researchandmarkets.com/research/g5r2nj/surgical_incision ) has announced the addition of ... report to their offering. The report provides ... , Japan , Europe ... , and Rest of World. This report ... Million by the following Product Segments: Stapler Products (Internal Stapler, ...
Breaking Medicine Technology:American Society of Addiction Medicine Releases National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use 2American Society of Addiction Medicine Releases National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use 3Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 3Surgical Incision Closures - Global Strategic Business Report 2015 2
... May 5 A voluntary recall has,been issued ... and,labeled with the Cardinal Health brand name. Hydrox ... individual mouthwash bottles and,those contained within Cardinal Health ... and been found positive for Burkholderia,cepacia (B. cepacia). ...
... Delivered Within Pre-Determined ... and Standard Dosing Limitations, BRIDGEWATER, N.J., May 5 ... SoloSTAR(R) disposable insulin pen,prefilled with Lantus(R) (insulin glargine [rDNA ... the pens,accurately delivered all insulin doses within standard limits ...
Cached Medicine Technology:Hydrox Inc., Cardinal Health Issue Nationwide Recall of Alcohol-Free Mouthwash For Hospitals 2New Study Confirms Dose-Accuracy of SoloSTAR(R) Prefilled Insulin Pen 2
(Date:6/2/2015)... The Horizon Blue Cross Blue Shield of ... and Wellness Challenge, held this past weekend during the ... $3,000 for the Boys & Girls Club of Atlantic ... steps on her fitbit during her play at the ... in Galloway Township. , When added to Horizon ...
(Date:6/2/2015)... 02, 2015 Bitscape Infotech today announced ... Microsoft Worldwide Small and Midsized Cloud Solutions Award. The ... Microsoft partners for demonstrating excellence in innovation and implementation ... “This comes as no surprise to us as we ... consecutively at worldwide level by Microsoft. We will continue ...
(Date:6/2/2015)... “ Radaris ” was featured on NewsWatch as part of ... and coolest applications on the market for iOS, Android, and ... conducted the app review and shared with viewers can help ... , According to Psychology Today, humans are a curious species ... curiosity is a part of human development. People are using ...
(Date:6/2/2015)... 02, 2015 Tronics, a designer and ... growth strategy to benefit from the significant growth expected ... May 2015 Status of the MEMS Industry report, we ... reach $6.6B in 2020,” says Frederic Breussin, Business Unit ... , The analyst adds that “although the BioMEMS market ...
(Date:6/2/2015)... On October 1, 2015 the transition to ICD-10 will ... On Monday, June 1st Congressman Kevin Brady, chairman ... Means Committee, and 12 members of the Committee sent ... urging the administration to provide a smooth transition for ... the newest coding system for healthcare professionals to code ...
Breaking Medicine News(10 mins):Health News:LPGA’s Natalie Gulbis Raises an Additional $3,000 for the Boys & Girls Club of Atlantic City Through Horizon BCBSNJ’s Walking and Wellness Challenge 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 3Health News:A Comprehensive People Search Application Was Featured on NewsWatch Television 2Health News:Tronics Aims to Benefit from Major Growth of Sensors and Related Technologies for Healthcare Applications 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 3Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 4
... report of death of a woman in Gopinathpur village after ... center camp has created much panic and confusion in the ... Mohapatra is said to have been operated (tubectomy) as a ... Monday. According to the victim’s husband, Sudarshan, Jayanti had complaints ...
... islands may well become quarantine areas if a flu epidemic ... behind this will be to contain the spread of the ... may also be transformed into emergency hospitals where basic medical ... Wellington Region is important as it has an international airport, ...
... secret of straight and curly hair lies four millimeters below ... trying to find the reason for the whitening of the ... and straight, for straight hair. ,To get to ... Bruno Bernard, head of hair biology at L'Oreal, grew curly ...
... to the Howard Hughes Medical Institute (HHMI) have discovered how ... its cloaking genes, and pass the human immune system.// ... be detected by the immune system, the remaining parasites can ... toll of 2.7 million human lives annually, mostly in Africa. ...
... in terminally ill patients who are dying of neurodegenerative ... in these patients, // views Professor Ian Wilmut, ... is appointed as the first director to the centre ... feels that stem cell research though in infant stage ...
... World wide concern regarding the use of poultry waste and feces ... the bird flu virus in the feces may be spread // ... and migratory birds leading to worldwide spread of the bird flu ... be due to contaminated feces which would have been used as ...
Cached Medicine News:Health News:Malaria’s Invisibility Code Identifie 2
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Reusable, stainless steel trephine with handle....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: